GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » Change In Inventory

TOT Biopharm International Co (HKSE:01875) Change In Inventory : HK$0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co Change In Inventory?

TOT Biopharm International Co's change in inventory for the quarter that ended in Dec. 2024 was HK$0 Mil. It means TOT Biopharm International Co's inventory stayed the same from Jun. 2024 to Dec. 2024 .

TOT Biopharm International Co's change in inventory for the fiscal year that ended in Dec. 2024 was HK$19 Mil. It means TOT Biopharm International Co's inventory declined by HK$19 Mil from Dec. 2023 to Dec. 2024 .

TOT Biopharm International Co's Total Inventories for the quarter that ended in Dec. 2024 was HK$116 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. TOT Biopharm International Co's Days Inventory for the quarter that ended in Dec. 2024 was 118.51.

Inventory Turnover measures how fast the company turns over its inventory within a year. TOT Biopharm International Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.54.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TOT Biopharm International Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.19.


TOT Biopharm International Co Change In Inventory Historical Data

The historical data trend for TOT Biopharm International Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co Change In Inventory Chart

TOT Biopharm International Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial 8.46 -26.26 -72.88 -34.11 18.52

TOT Biopharm International Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TOT Biopharm International Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOT Biopharm International Co  (HKSE:01875) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TOT Biopharm International Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=119.3935/183.855*365 / 2
=118.51

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

TOT Biopharm International Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TOT Biopharm International Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOT Biopharm International Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


TOT Biopharm International Co Business Description

Traded in Other Exchanges
N/A
Address
120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.
Executives
Center Laboratories, Inc. 2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited 2301 Trustee
Chengwei Evergreen Capital, Lp 2101 Beneficial owner
Center Laboratories Inc. 2101 Beneficial owner
Chengwei Evergreen Management, Llc 2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited 2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines